Ramelius Resources shareholders got a double treat this morning: Another takeover target and confirmation of FY23 guidance!

Nick Sundich Nick Sundich, July 3, 2023

Ramelius Resources (ASX:RMS) had two pieces of good news this morning. First, that it would be growing its portfolio by acquiring Musgrave Minerals (ASX:MGV). And second, that it had met its FY23 guidance.

 

SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW!

 

Ramelius had a strong FY23

Ramelius finished FY23 having produced 240,996oz gold, thus meeting FY23 guidance, and sold 243,263. The WA gold miner produced 68,752oz in Q4 alone and closed with a cash (and gold on hand) balance of A$272.1m. This was up from $154.4m just three months earlier.

Ramelius delivered positive cash flow of $42.6m after accounting for the $75.1m acquired from the Breaker acquisition. This was due to an increase in forecasted production from the high-grade, high-margin penny mine.

 

And it could be better in FY24

Ramelius announced the worst kept secret on the ASX. It was buying out Cue Gold project owner Musgrave Minerals (ASX:MGV). Cue is a solid deposit with 12.3Mt @ 2.3g/t for 927,000 ounces of gold.

The Musgrave board opted to cash out rather than try and develop it themselves, arguing a takeover now was a win-win for all parties.

If Musgrave shareholders accept, they’ll get 1 RMS share for each 4.21 MGV shares held along with $0.04c in cash for each MGV share held. This deal values Musgrave at $201m, equating to $0.34 per share.

This was only a modest 19% premium to Friday’s closing price but was 27% higher than an indicative offer from Westgold (ASX:WGX) barely a month earlier.

 

Stocks Down Under Concierge is here to help you pick winning stocks!

The team at Stocks Down Under have been in the markets since the mid-90s and we have gone through many ups and downs. We have written about every sector!

Our Concierge BUY and SELL service picks the best stocks on ASX. We won’t just tell you what to buy – we give you a buy range, price target, a stop loss level in order to maximise total returns and (of course) we tell you when to sell. And we will only recommend very high conviction stocks where substantial due diligence has been conducted.

Our performance is well ahead of the ASX200 and All Ords.

You can try out Concierge for 3 monthsfor FREE.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

There’s no credit card needed – the trial expires automatically.

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Kamala Harris stocks

Kamala Harris stocks: If Joe Biden’s VP wins the White House in 2024, which stocks will win?

With the US Presidential election now certain to be a Kamala Harris v Donald Trump showdown, we’ve looked at so-called…

South32

South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?

South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-2024, it is capped…

drug reimbursement

Here’s why drug reimbursement is so important for ASX healthcare stocks

Let’s take a look at the concept of drug reimbursement, something that is crucial for ASX healthcare stocks looking to…